XML 44 R33.htm IDEA: XBRL DOCUMENT

Related Party Disclosures	6 Months Ended
Related Party Disclosures	Jun. 30, 2019
Related Party Transactions [Abstract]
Related Party Disclosures	Related Party Disclosures On October 1, 2018, the Company entered into the Investment Agreement with the Purchaser relating to the issuance to the Purchaser of $150,000 aggregate principal amount of the Notes. In connection with the investment, Vikram S. Pandit, Chairman and CEO of The Orogen Group LLC (an affiliate of the Purchaser), was appointed to Company’s Board of Directors. The Company had outstanding Notes with a principal amount of $150,000 as of June 30, 2019 and December 31, 2018 and interest accrued of $1,313 each as of June 30, 2019 and December 31, 2018, related to the Investment Agreement. Refer Note 18 to the unaudited consolidated financial statements for details. The Company provides consulting services to PharmaCord, LLC. One of the Company’s directors, Nitin Sahney, is the member-manager and chief executive officer of PharmaCord, LLC. The Company recognized revenue of $nil each during the three and six months ended June 30, 2019, and $16 and $215 during the three and six months ended June 30, 2018, respectively, for services provided. As of June 30, 2019 and December 31, 2018, the Company had accounts receivable of $nil and $5, respectively, related to these services.